LEERINK Partners, a healthcare investment bank, announced that Chad Moore has joined its investment banking team as a managing director and will lead the pharmaceutical outsourcing effort.

Mr. Moore brings over 20 years of experience and expertise to LEERINK Partners. Most recently, he was the head of the pharmaceutical services and IT sector coverage teams at Robert W. Baird and advised clients on more than 25 transactions during his tenure. Earlier this year, Mr. Moore advised Nautic Partners on the sale of Theorem Clinical Research to Chiltern International. Prior to Baird, Mr. Moore worked at PRA Health Sciences (formerly PRA International), a contract research organization, where he worked closely with executive management and oversaw PRA’s corporate development activities.

“We are excited to have Chad on board as we continue to build out the Healthcare Services franchise,” said Doug Brown, senior managing director and head of healthcare services. “Chad’s expertise in pharmaceutical outsourcing will enhance our efforts with both corporate and financial sponsor clients. Outsourced pharmaceutical services is a very important sector for the firm, as a natural extension of LEERINK’s highly successful Life Sciences franchise.”

“LEERINK has distinguished itself in the healthcare investment banking industry with their knowledge-driven platform, and I am thrilled to being joining this experienced team of dedicated healthcare professionals,” said Mr. Moore. “I look forward to furthering LEERINK’s capabilities and contributing to the Firm’s ongoing growth and success.”